Haemonetics has been granted a patent for a blood component cooling container with cooling vanes that increase surface area. The container is tapered and has a frustum shape, with an opening to receive collected plasma. The design aims to improve cooling efficiency and ease of use. GlobalData’s report on Haemonetics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Haemonetics, Glucose monitoring wearbles was a key innovation area identified from patents. Haemonetics's grant share as of May 2024 was 47%. Grant share is based on the ratio of number of grants to total number of patents.
Blood component cooling container with increased surface area
A recently granted patent (Publication Number: US11963931B2) discloses a blood component cooling container designed to efficiently store plasma. The container features a tapered, frustum-shaped body with cooling vanes extending along its length to increase the external surface area. This design aims to reduce freezing and defrosting times for the plasma stored within. Additionally, a flexible metallic frame on the external surface enhances heat exchange properties. The container includes an opening at the proximal end to facilitate easy access to the collected plasma. The patent also details a method for storing plasma in the container, involving transferring plasma from a blood component separation device to the container, freezing, defrosting, and removing the plasma using an automatic bottle opener.
Furthermore, the patent describes variations in the number of cooling vanes, ranging from four to twelve, to suit different cooling needs. The inclusion of a flexible metallic frame that contacts the bottom and sides of the container further enhances heat exchange efficiency. Another embodiment of the blood component cooling container includes convection members with indents or slits along the body portion to increase the external surface area. These features collectively aim to improve the storage and retrieval process of plasma, ensuring optimal preservation and usability. Overall, the patent highlights innovative design elements and methods that address the challenges associated with storing blood components, particularly plasma, in a clinical or laboratory setting.
To know more about GlobalData’s detailed insights on Haemonetics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
